News
News

The latest updates from AFAR.

Experts in the News: May Hua and R. Sean Morrison AFAR-funded research on how palliative care can reduce the need for intensive care units in JAMA Network Open

Jan 14
2020

Experts in the News: May Hua and R. Sean Morrison AFAR-funded research on how palliative care can reduce the need for intensive care units in JAMA Network Open

On January 8, 2020, JAMA Network Open published new AFAR-funded research by AFAR experts May Hua, MD, MSc, and R. Sean Morrison, MD that found that implementing hospital-based palliative care services in New York State reduces treatment intensity at the end of life for hospitalized patients. Dr. Hua is a 2015 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, as well as an Assistant Professor of Anesthesiology (In Epidemiology) at the Columbia University Medical Center. Dr. Morrison is a 2000 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. He is also an Ellen and Howard C. Katz…


View MoreREAD MORE


Experts in the News: Research by Valter Longo and Rafael DeCabo on intermittent fasting, immune health and inflammaging in Forbes

Jan 14
2020

Experts in the News: Research by Valter Longo and Rafael DeCabo on intermittent fasting, immune health and inflammaging in Forbes

On January 6, 2020, Forbes spotlighted research by AFAR experts Valter Longo, PhD and Rafeael DeCabo, PhD in an article exploring how intermittent fasting may improve immune health and reduce age-related inflammation. The piece references a 2014 study in Cell Stem Cell by Dr. Longo on how fasting lowers white blood cell counts, which in turn triggers the production of new white blood cells and strengthens the immune system. The article next spotlights a recent study in the New England Journal of Medicine by Dr. DeCabo that explores how fasting also helps with weight loss and reducing inflammation. Dr. Longo is a 1998 AFAR…


View MoreREAD MORE


Board Members in the News: Nir Barzilai and David Sinclair discuss advances in geroscience and clinical interventions Newt’s World podcast

Jan 08
2020

Board Members in the News: Nir Barzilai and David Sinclair discuss advances in geroscience and clinical interventions Newt’s World podcast

On January 5, 2020,  Newt’s World podcast featured AFAR experts Nir Barzilai, MD, and David Sinclair, PhD, AO. In the podcast hosted by retired politician Newt Gingrich, the AFAR experts discussed how advances geroscience are leading to therapeutic interventions to extend healthspan, and the cultural shift and multi-sector support needed to move aging research from the labs into our lives. The longevity dividend of healthcare savings by extending healthspan, as well as insights learned from “superager” centenarians also are discussed. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR…


View MoreREAD MORE


Experts in the News: Steven Austad and Stephen Kritchevsky on how to prevent Inflammaging in The New York Times

Jan 06
2020

Experts in the News: Steven Austad and Stephen Kritchevsky on how to prevent Inflammaging in The New York Times

On December 23, 2019, The New York Times featured insights from AFAR experts Steven N. Austad, PhD, and Stephen B Kritchevsky, PhD, on how eliminating senescent cells and regular exercise can reduce age-related inflammation, or inflammaging, and extend healthspan. The article also emphasizes the potential of metformin to prevent inflammaging, which will be tested in the upcoming TAME Trials. Dr. Austad is AFAR’s Scientific Director. He is also a distinguished professor and Chair of the Department of Biology at the University of Alabama at Birmingham, as well as Co Principle-Investigator of the Nathan Shock Centers of Excellence in the Basic…


View MoreREAD MORE


Experts in the News: Nir Barzilai and Lynne Cox scientific advances to extend healthspan in The Guardian

Jan 02
2020

Experts in the News: Nir Barzilai and Lynne Cox scientific advances to extend healthspan in The Guardian

On December 21, 2019, The Guardian featured insights from AFAR experts Nir Barzilai, MD, and Lynne Cox, PhD, on scientific advances to slow aging and extend healthspan. Dr. Barzilai discusses the potential impact of the TAME Trial to provide proof-of-concept that the biology of aging can be targeted with drugs like metformin and others. Dr. Cox provides her expertise on cellular senescence and senolytic drugs. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S.…


View MoreREAD MORE


Board Member in the News: S. Jay Olshansky on presidential candidate’s healthspan in The Washington Post

Jan 02
2020

Board Member in the News: S. Jay Olshansky on presidential candidate’s healthspan in The Washington Post

On December 17, 2019, The Washington Post featured insights by AFAR expert S. Jay Olshansky, PhD, on Joe Biden’s recent three page health summary, and why the candidate’s workout regimen is a sign of his good health. Dr. Olshansky’s recent AFAR-published whitepaper, Longevity and Health of US Presidential Candidates for the 2020 Election, emphasizes the importance of assessing healthspan-- not chronological age—when considering a presidential candidate’s fitness. Dr. Olshansky is an AFAR board member and 2016 Irving S. Wright Award recipient. He is currently a Professor in the School of Public Health at the…


View MoreREAD MORE


Grantee in the News: Reisa Sperling on the early signs of dementia and Alzheimer’s in The Boston Globe

Jan 16
2020

Grantee in the News: Reisa Sperling on the early signs of dementia and Alzheimer’s in The Boston Globe

On January 10, 2020, The Boston Globe featured insights from AFAR expert Reisa Sperling, MD, on the early signs one should look out for that are often associated with dementia and Alzheimer’s Disease. Dr. Sperling is a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient. She is also the Co-Investigator of Neuroimaging Core at the Massachusetts Alzheimer's Disease Research Center, the Director of the Center for Alzheimer Research at Brigham and Women’s Hospital, and a Professor of Neurology at Harvard Catalyst. Read the article, “Signs of early-onset Alzheimer’s: When not to…


View MoreREAD MORE


Grantee in the News: David Gate’s on T Cell Receptors and immune changes in Alzheimer’s patients in Nature

Jan 16
2020

Grantee in the News: David Gate’s on T Cell Receptors and immune changes in Alzheimer’s patients in Nature

On January 8, 2020, Nature published research by AFAR expert David Gate, PhD. Supported in part an AFAR grant, the research uses clonally expanded T Cell Receptors (TCRs) in the cerebrospinal fluid of patients with Alzheimer’s disease to identify peripheral and central adaptive immune changes in patients. Dr. Gates is a 2015 Glenn Foundation for Medical Research Postdoctoral Fellowship in Aging Research recipient, as well as a 2019 Irene Diamond Fund/AFAR Postdoctoral Transition Awards in Aging recipient. He is a Postdoctoral Research Fellow of Neurology and Neurological Sciences at Stanford University. The research was partially funded by Dr. Gate’s…


View MoreREAD MORE


test

Jan 16
2020



BACK TO TOPBACK TO TOP